“Sweet sleep! You come like pure happiness, uninvited, most willingly when not begged for.”
Johann Wolfgang von Goethe, “Roman Elegies” (1795)
Sleep disorders are among the most common health issues these days. While traditional sleep aids often come with a high risk of dependency and serious side effects, many people are looking for natural alternatives. The natural cannabinoid cannabidiol (CBD), which can also be extracted from industrial hemp, is increasingly being discussed as a potential option. But what do recent scientific studies actually show about CBD for sleep disorders?
How does CBD work in the brain when it comes to sleep disorders?
To understand the possible effects of CBD on sleep, it’s worth taking a look at the mechanisms of action . CBD interacts with the body’s own endocannabinoid system , which is involved in regulating sleep-wake cycles, among other things. Unlike the psychoactive (temporarily mind-altering) delta-9-THC, CBD binds only weakly to the endocannabinoid CB1 receptors, but modulates many other receptor systems in our bodies . Here’s a quick overview of some well-known possible mechanisms of action when it comes to sleep disorders:
1. Modulation of the endocannabinoid system: CBD increases the concentration of our body’s own cannabinoid anandamide (AEA) by inhibiting the enzyme FAAH (fatty acid amide hydrolase) that breaks it down. Research suggests that higher anandamide levels could promote deep sleep. A systematic review by Peng et al. (2022) (2) in Basic & Clinical Pharmacology & Toxicology describes how this FAAH inhibition could lead to improved sleep parameters, especially staying asleep through the night.
2. Effect on the adenosine pathway: A particularly relevant mechanism for promoting sleep is CBD’s effect on the adenosine system. Adenosine is a natural messenger in the body that builds up during wakefulness and signals tiredness. By inhibiting adenosine reuptake, CBD could enhance this natural sleep mechanism (4).
3. GABA modulation: CBD also interacts with our body’s GABA-A receptors, the main inhibitory neurotransmitter receptors in the brain. At higher doses, CBD can boost GABA activity, which may have a calming and sleep-promoting effect. Since GABA dampens neural excitability, this mechanism could be especially relevant for staying asleep (5).
4. Anxiety-reducing effects via serotonin receptors: CBD interacts with serotonin receptors, which play a role in anxiety and mood regulation. Since sleep problems often go hand in hand with anxiety and anxiety disorders, part of the sleep-promoting effect could be due to its anxiolytic (anxiety-reducing) properties. A systematic review by Blessing et al. (2015) (1) in the journal Neurotherapeutics describes these anxiety-reducing effects of CBD in detail.
These multiple mechanisms of action might explain why CBD could be especially helpful for stress- and anxiety-related sleep disorders, while the effects seem less pronounced for primary sleep disorders without a psychological component.
What recent studies say about CBD and sleep quality
Two things up front:
1. The natural cannabinoid CBD can’t be patented (similar to melatonin), so there’s a lack of pharma resources for the very expensive randomized clinical trials (RCTs) that are usually considered the gold standard. This explains some of the gaps in the evidence. Preclinical research (like animal models) provides plausibility, but human data is limited and doesn’t guarantee effectiveness in people. The same goes for many nutraceuticals and herbal remedies.
2. The evidence on CBD as a single substance might not say much about full-spectrum CBD products. Preclinical findings suggest there could be synergistic effects with other cannabinoids and terpenes (entourage effect), but human data on this is scarce.
Important note: The following information is based on published studies and is not a substitute for medical advice. CBD is not an approved medicine for sleep disorders (Swissmedic/BAG). Effectiveness is not proven; individual results may vary. If needed, talk to a doctor.
The research on CBD and sleep has grown in recent years, but overall it’s still limited. Some of the most relevant work includes a meta-analysis of randomized clinical trials by Kuhathasan et al. (2019), which points to possible mild improvements in sleep quality for anxiety-related disorders (6), as well as a randomized clinical trial by Ried et al. (2023) in the Journal of Sleep Research (24 insomnia patients, THC:CBD combo), which reported improvements in subjective sleep quality (+80%, small sample size) (7).
Additionally, the Scoping Review by Amaral et al. (2023) summarizes preclinical and clinical data and discusses potential sedative effects of CBD at higher doses (8). A frequently cited retrospective study by Shannon et al. (2019) looked at 72 adults with anxiety and sleep problems (9). After one month of taking CBD (25–175 mg daily), over 66 percent reported subjective changes in their sleep, though the effects varied.
A randomized, placebo-controlled study by Skelley et al. (2020) examined the effects of four weeks of CBD supplementation on various health parameters (10). While some sleep markers improved subjectively, the effects weren’t always statistically significant compared to placebo.
A systematic review by Suraev et al. (2020) analyzed 34 studies on cannabis, cannabinoids, and sleep (11). The authors concluded that the evidence for CBD in sleep disorders is insufficient and that higher-quality studies are needed.
Can CBD help you fall asleep – and at what dose?
The question of the optimal CBD dose for sleep problems can’t be answered clearly at this time. The doses used in studies vary widely – from 25 mg up to 300 mg or more per day.
Interestingly, some studies suggest a biphasic effect: lower doses seem to be more stimulating, while higher doses might have a sedating effect. An older study by Nicholson et al. (2004) showed that 15 mg of CBD had a stimulating effect, while other studies with higher doses observed sleep-promoting effects (12).
The Swiss Federal Office of Public Health (BAG) has classified CBD products with a THC content below one percent as food, but doesn't make any specific dosage recommendations for therapeutic use. People considering CBD for sleep problems should start with low doses and increase them slowly, ideally in consultation with a healthcare professional.
Could CBD improve total sleep time or just help you fall and stay asleep?
The available studies show different results regarding the specific sleep parameters affected by CBD. While some research shows improvements in subjectively perceived sleep quality, the effects on objectively measurable parameters like total sleep time are less clear.
A small study by Carlini and Cunha (1981) observed that higher CBD doses (160 mg) increased total sleep time in people with insomnia (13).
Some research suggests that CBD might be especially helpful for stress-related sleep problems by reducing underlying anxiety or tension, but less so for primary sleep disorders without a psychological component.
What are the differences between CBD, THC, and traditional sleeping pills?
An important aspect when evaluating CBD is distinguishing it from THC and conventional sleeping medications. THC, the main psychoactive compound in cannabis, shows more pronounced sedative effects in studies compared to CBD, but also causes psychoactive effects up to strong temporary changes in consciousness and has a higher potential for dependence.
Traditional benzodiazepines and Z-drugs (like zolpidem) are effective for sleep disorders, but come with major risks like tolerance, dependence, and disruption of sleep architecture. A review by Babson et al. (2017) in Current Psychiatry Reports discusses that cannabinoids could be an interesting alternative treatment option, but also highlights the lack of sufficient data (14).
A potential advantage of CBD over traditional sleeping pills could be its lower risk of dependence. The World Health Organization (WHO) stated in a 2018 report that CBD does not show any abuse or dependence potential in humans (15).
How long has CBD been tested for sleep problems in recent studies?
Most available studies on CBD and sleep are short-term, with treatment durations ranging from a few weeks up to three months. Long-term studies lasting six months or more are largely missing.
The previously mentioned study by Shannon et al. (2019) observed participants over three months. The authors noted that the initial improvements in sleep scores fluctuated over time, raising questions about the sustainability of the effects (9). Long-term studies are urgently needed to properly assess the long-term safety and lasting effectiveness of CBD for chronic sleep problems.
What side effects were reported in the new CBD sleep studies?
An important aspect when evaluating any treatment option is the side effect profile. In most studies on CBD, the substance was relatively well tolerated, with the most commonly reported side effects being mild.
In the study by Shannon et al. (2019), some participants reported tiredness and diarrhea, but only to a small extent. A systematic review by Chesney et al. (2020) in Cannabis and Cannabinoid Research analyzed side effects from 25 studies and found that CBD was generally well tolerated, with the most common side effects being tiredness, diarrhea, and changes in appetite (16).
It's important to note, however, that CBD can interact with various medications because it's metabolized by the cytochrome P450 system in our liver, which also breaks down other drugs. People taking other medications should definitely consult a doctor before using CBD.
Are there studies on CBD for insomnia, nightmares, or PTSD-related sleep problems?
A particularly interesting area of research is the use of CBD for specific sleep disorders in the context of mental health conditions. Several studies have looked at CBD for post-traumatic stress disorder (PTSD), which often comes with sleep problems and nightmares.
A case series by Elms et al. (2019) (17) in the Journal of Alternative and Complementary Medicine reported improvements in PTSD symptoms, including sleep quality, in adults who took CBD. However, the sample size was small and there was no control group.
Shannon and Opila-Lehman (2016) (18) published a case report in the Permanente Journal about a child with PTSD whose sleep quality improved and anxiety symptoms decreased with CBD. While such individual case reports are interesting, they can't be generalized.
For the specific diagnosis of primary insomnia without comorbid mental health conditions, high-quality studies are largely lacking. The European Medicines Agency (EMA) has not yet approved any CBD products for the treatment of sleep disorders.
How quickly does CBD start to affect sleep according to studies?
The pharmacokinetics of CBD vary greatly depending on the form of administration. When taken orally (oils, capsules), the time to reach maximum plasma concentrations is typically one to two hours. The bioavailability with oral use is only about 6 to 19 percent due to first-pass metabolism, the chemical conversion of the active ingredient in the liver.
There is little precise data on how quickly CBD affects sleep parameters. In clinical studies, CBD was usually taken for several days or weeks before effects were evaluated. Some user reports suggest relatively quick effects within days, but there are no systematic studies on the timeline.
When using CBD oils sublingually and, of course, when inhaling, the effects can theoretically kick in faster than with capsules, since some of the active ingredient is absorbed directly through the mucous membranes in your mouth or through your lungs into your bloodstream.
What do Swiss experts and authorities say about CBD for sleep problems?
In Switzerland, CBD products with less than one percent THC are classified as food and not as medicine. The Federal Office of Public Health (BAG) has made it clear that no therapeutic health claims can be made for these products.
Swissmedic, the Swiss agency for the authorization and supervision of medicines, has so far approved only a few CBD-based medicines. There’s no official approval for sleep disorders.
Professional societies like the Swiss Society for Sleep Research, Sleep Medicine and Chronobiology (SGSSC) haven’t officially commented on using CBD for sleep problems. Current guidelines for treating insomnia mainly recommend behavioral therapy approaches and, if needed, short-term use of sleep meds.
Can CBD replace classic sleeping pills or just complement them?
Based on current studies, CBD can’t be recommended as a replacement for established sleep therapies. The evidence is still too limited and the effects in many studies are moderate.
For people with mild sleep issues or trouble falling asleep due to stress, CBD might be a possible add-on option, especially if conventional treatments aren’t tolerated or aren’t wanted. But you should always talk to a healthcare professional about it first.
For chronic insomnia, cognitive behavioral therapy for insomnia (CBT-I) is considered the gold standard and should be the first line of treatment. A meta-analysis by Trauer et al. (2015) in the Annals of Internal Medicine showed the high effectiveness of this non-pharmacological therapy.
Which CBD form (oil, capsules, etc.) is currently considered best for sleep?
Most clinical studies on CBD and sleep used oral forms, either oil or capsules. Direct comparison studies between different application methods are mostly lacking.
Sublingual CBD oils theoretically offer the advantage of flexible dosing and possibly faster absorption. Capsules, on the other hand, allow for more precise dosing and are tasteless.
For inhaling CBD (using a vaporizer) there’s hardly any data on its use for sleep problems. This method leads to higher bioavailability and faster onset of effects.
How can you spot high-quality CBD products for people with sleep problems?
The quality of CBD products varies a lot on the market. If you’re considering CBD for sleep issues, look for these quality features:
Lab analysis certificates should confirm the exact CBD content and the absence of contaminants like heavy metals, pesticides, and solvent residues. Reputable manufacturers make these certificates publicly available.
The THC content should be below one percent in Switzerland and clearly stated. Products should come from controlled cultivation and ideally be made according to GMP standards (Good Manufacturing Practice).
Full-spectrum CBD oils contain not just CBD but also other cannabinoids and terpenes, which might have synergistic effects (the so-called entourage effect). CBD isolates, on the other hand, contain only pure CBD. Which type is better can’t be answered scientifically yet.
Conclusion: What’s the deal with the CBD hype for sleep problems?
The scientific evidence on CBD and sleep problems has grown a lot in recent years, but it’s still not enough for any definite conclusions. While some studies suggest potential benefits, especially for stress- and anxiety-related sleep issues, large, high-quality, placebo-controlled long-term studies are still missing.
Since CBD can’t be patented, we’ll probably see more growth in the often underrated “real world evidence” for now: RWE means insights from data collected in real life – like patient records, apps, insurance data, or registries. Unlike strict clinical studies with fixed groups, placebos, and controls, they show how something like CBD works for lots of people with different life situations, meds, and issues.
So far, research suggests that CBD might help some people with mild to moderate sleep problems, especially when these are linked to anxiety or stress. But the effects seem to vary a lot from person to person and aren’t comparable to the effectiveness of established sleep therapies.
If you’re thinking about trying CBD for sleep problems, it’s important to keep your expectations realistic and not see it as a replacement for proven treatments. A mix of better sleep habits, possibly cognitive behavioral therapy, and medical treatment if needed should be the foundation of your approach.
Legal disclaimer
This article is for information only and doesn’t replace medical advice. The content is based on the status as of January 2026; new findings may change things. Always consult a healthcare professional before using CBD. The author and Heimatkult.ch accept no liability for the use of this information.
Scientific sources
1. Blessing, E. M., Steenkamp, M. M., Manzanares, J. & Marmar, C. R. (2015). Cannabidiol as a Potential Treatment for Anxiety Disorders. Neurotherapeutics , 12(4), 825–836.
2. Peng, J., Fan, M., An, C., Ni, F., Huang, W. & Gu, J. (2022). A narrative review of molecular mechanism and therapeutic effect of cannabidiol (CBD). Basic & Clinical Pharmacology & Toxicology , 130(4), 439–456.
3. Carrier, E. J., Auchampach, J. A. & Hillard, C. J. (2006). Inhibition of an equilibrative nucleoside transporter by cannabidiol: A mechanism of cannabinoid immunosuppression. Proceedings of the National Academy of Sciences , 103(24), 9304–9309.
4. D’Angelo, M. & Steardo Jr, L. (2024). Cannabinoids and Sleep: Exploring Biological Mechanisms and Therapeutic Potentials. International Journal of Molecular Sciences, 25(7), 3603.
5. Bakas, T., van Nieuwenhuijzen, P. S., Devenish, S. O., McGregor, I. S., Arnold, J. C. & Chebib, M. (2017). The direct actions of cannabidiol and 2-arachidonoyl glycerol at GABAA receptors. Pharmacological Research, 119, 358–370.
6. Kuhathasan, N., Dufort, A., MacKillop, J., Gottschalk, R., Minuzzi, L. & Frey, B. N. (2019). The use of cannabinoids for sleep: A critical review on clinical trials. Experimental and Clinical Psychopharmacology, 27(4), 383–401.
7. Ried, K., Tamanna, T., Matthews, S. & Oliver-Pyatt, R. (2023). Medicinal cannabis improves sleep in adults with insomnia: a randomised double-blind placebo-controlled crossover study. Journal of Sleep Research, 32(3), e13793.
8. Amaral, C., Ferreira, S., Silva, A. & Remião, F. (2023). Cannabis and sleep disorders: not ready for prime time? A scoping review. Journal of Clinical Medicine, 12(9), 3188.
9. Shannon, S., Lewis, N., Lee, H. & Hughes, S. (2019). Cannabidiol in Anxiety and Sleep: A Large Case Series. The Permanente Journal, 23, 18-041.
10. Skelley, J. W., Deas, C. M., Curren, Z. & Ennis, J. (2020). Use of cannabidiol in anxiety and anxiety-related disorders. Journal of the American Pharmacists Association, 60(1), 253–261.
11. Suraev, A. S., Marshall, N. S., Vandrey, R., McCartney, D., Benson, M. J., McGregor, I. S., Grunstein, R. R. & Hoyos, C. M. (2020). Cannabinoid therapies in the management of sleep disorders: A systematic review of preclinical and clinical studies. Sleep Medicine Reviews, 53, 101339.
12. Nicholson, A. N., Turner, C., Stone, B. M. & Robson, P. J. (2004). Effect of Δ-9-tetrahydrocannabinol and cannabidiol on nocturnal sleep and early-morning behavior in young adults. Journal of Clinical Psychopharmacology, 24(3), 305–313.
13. Carlini, E. A. & Cunha, J. M. (1981). Hypnotic and antiepileptic effects of cannabidiol. The Journal of Clinical Pharmacology, 21(S1), 417S–427S.
14. Babson, K. A., Sottile, J. & Morabito, D. (2017). Cannabis, Cannabinoids, and Sleep: a Review of the Literature. Current Psychiatry Reports, 19(4), 23.
15. World Health Organization. (2018). Cannabidiol (CBD) Critical Review Report. Expert Committee on Drug Dependence.
16. Chesney, E., Oliver, D., Green, A., Sovi, S., Wilson, J., Englund, A., Freeman, T. P. & McGuire, P. (2020). Adverse effects of cannabidiol: a systematic review and meta-analysis of randomized clinical trials. Neuropsychopharmacology, 45(11), 1799–1806.
17. Elms, L., Shannon, S., Hughes, S. & Lewis, N. (2019). Cannabidiol in the Treatment of Post-Traumatic Stress Disorder: A Case Series. The Journal of Alternative and Complementary Medicine, 25(4), 392–397.
18. Shannon, S. & Opila-Lehman, J. (2016). Effectiveness of Cannabidiol Oil for Pediatric Anxiety and Insomnia as Part of Posttraumatic Stress Disorder: A Case Report. The Permanente Journal, 20(4), 108–111.
19. Trauer, J. M., Qian, M. Y., Doyle, J. S., Rajaratnam, S. M. & Cunnington, D. (2015). Cognitive Behavioral Therapy for Chronic Insomnia: A Systematic Review and Meta-analysis. Annals of Internal Medicine, 163(3), 191–204.
